MeMed

At MeMed, a leader in host response technologies, we decode the body’s complex signals into simple insights that transform the way diseases are diagnosed and treated. Run on the MeMed Key®, the MeMed BV® accurately differentiates bacterial from viral infection, enabling improved patient management, including appropriate antibiotic use, helping address the global healthcare challenge of antimicrobial resistance. Based on computational integration of bacterial and viral-responsive immune proteins, Key delivers the BV result in 15 minutes from serum; this test was clinically validated on thousands of patients, is CE-marked and FDA cleared.